Extortion racket within NCB: Minister Nawab Malik shares official’s letter

News Network
October 26, 2021

Mumbai, Oct 26: NCP chief spokesperson and Maharashtra’s minority affairs minister Nawab Malik on Tuesday shared a letter from an unnamed NCB official alleging fraud with the anti-drugs agency, firing yet another salvo at NCB’s Mumbai Zonal Director Sameer Wankhede. 

Malik, who said he is forwarding the letter to NCB DG SN Pradhan, urged the agency to look into 26 allegations in the letter claiming an "extortion racket" being run within the anti-drugs agency. 

In the letter, the unnamed officer, who claimed that he has been working in the Mumbai NCB bureau for the past two years, alleged that Rakesh Asthana directed Sameer Wankhede and K P S Malhotra to register fake cases against Bollowood stars and extract money from them. 

The officer alleged that Wankhede and Malhotra filed 'fake cases' against Deepika Padukone, Shraddha Kapoor, Rakul Preet Singh, Sara Ali Khan, Bharti Singh and others extracted crores of rupees via their lawyer.

"Here are the contents of the letter received by me from an unnamed NCB official. As a responsible citizen I will be forwarding this letter to DG Narcotics requesting him to include this letter in the investigation being conducted on Sameer Wankhede," Malik said in a tweet.

Malik has alleged collusion between the NCB and the BJP leaders in the drugs-on-cruise case in which Aryan Khan, superstar Shah Rukh Khan's son, has been identified as the accused number 1.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 9,2025

Mangaluru: In a significant development, Mescom has proposed a phased electricity tariff hike starting with Rs 0.70 per unit for the fiscal year 2025-26. The proposal has been submitted to the Karnataka Electricity Regulatory Commission (KERC) for approval, signaling a potential increase in electricity costs for consumers.

Mescom emphasized that the current tariff structure is insufficient to meet operational expenses and manage revenue effectively. To address this, the company has invited public objections to the proposed hike.

Currently, the electricity supply cost is Rs 9.23 per unit, while the consumer tariff stands at Rs 8.53 per unit, leading to a shortfall of Rs 0.70 per unit. For the financial year 2023-24, Mescom reported revenue of Rs 5,924.73 crore against an expenditure of Rs 6,310.39 crore, resulting in a deficit of Rs 367.66 crore. For the 2025-26 fiscal year, projected revenue is Rs 5,850.81 crore, with an actual requirement of Rs 5,961.63 crore, creating a deficit of Rs 110.82 crore.

In a first, Mescom has submitted a multi-year tariff revision proposal to KERC. The plan outlines a hike of Rs 0.70 per unit for 2025-26, followed by Rs 0.37 per unit for 2026-27 and Rs 0.54 per unit for 2027-28.

"An increase in electricity tariff is inevitable," stated Jayakumar R, Managing Director of Mescom. "Mescom has submitted a proposal in this regard to KERC."

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 4,2025

shivarajkumar.jpg

Bengaluru, Jan 4: Kannada star Dr Shivarajkumar, son of Kannada film legend Dr Rajkumar, has been discharged from the hospital in Miami, US, following complete recovery from cancer, family sources confirmed on Saturday.

Nivedita, Shivarajkumar’s daughter, has shared a picture showing the actor and family in a relaxed mode. Sources further stated that Shivarajkumar will be in the US for follow-ups and resting for one month and he will be back for the shooting by Feb first or the second week.

Shivarajkumar is expected to begin shooting of the Telugu superstar Ramcharan-starrer pan India movie soon. 

Earlier, Shivarajkumar shared a video from the US on the first day of 2025, detailing his journey of overcoming cancer and assuring fans of his return.

In the video, he conveyed his New Year wishes to everyone and said, “I am hesitant to speak as I might get emotional at this moment. Leaving Karnataka was a very emotional experience for me. Under these circumstances, fear is inevitable, but the support of my fans has significantly reduced it.”

He continued, “The way the doctors took care of me, gave me immense courage. While shooting for the movie ‘45’, I underwent chemotherapy and even filmed the climax fight scene. As the date to leave for the US for treatment approached, I became anxious. However, my wife Geetha and daughter Nivedita stood by me throughout.”

“Dr Manohar, who treated me, cared for me like a child. My urinary bladder has been replaced, but there is no need for anyone to panic. I am doing well and will be back with double the energy. I thank all my fans for their unwavering support,” Shivarajkumar assured.

Geetha Shivarajkumar, his wife, who had appeared in the video alongside him, stated that all the medical reports had come back negative, and it was officially declared that Shivarajkumar is cancer-free. “He recovered because of the blessings of his fans, and I will never forget this,” she said.

The actor underwent surgery at a hospital in Miami, US, where his cancerous bladder was removed. According to the surgeon, Dr Murugesh Manoharan, an artificial bladder was created using Shivarajkumar’s intestine.

In November, Shivarajkumar had spoken publicly about his illness, acknowledging that he was human like everyone else. While he didn’t disclose it was cancer at the time, he said, “At the end of the day, I am a human being. I have a health issue and am currently undergoing treatment for it. I have completed a couple of treatment sessions, and a few more are pending. After that, I will undergo surgery, either in India or the US.”

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 6,2025

Bengaluru: An eight-month old baby has been detected with the human metapneumovirus (HMPV) in a Bengaluru hospital on Monday, with reports going viral online. This is likely the first reported case of HMPV in the country after the recent spike in China.

The baby is reportedly undergoing treatment in a private hospital in northern Bengaluru.

The Karnataka state health department has maintained that there is no cause for concern.

"We don't know what strain of virus is spreading in China. Without knowing that, we cannot say that this reported case is concerning. We have been reviewing all influenza-like illnesses (ILIs) from December to check for any strain that is concerning. There is no such concerning spike across the state or country," said a well-placed source in the state health department.

The HMPV is a known virus (first discovered in 2001) that causes respiratory symptoms similar to that of a common cold, largely affecting children below the age of five. It is not a new virus.

Cases have been reported in the past, especially in the winter season, note experts and health department officials, making it not an immediate concern, unless an unusual spike is observed.

In December 2024, 714 suspected cases of HMPV were tested in 16 Virus Research and Diagnostic Laboratories (VRDLs) across the country, of which only nine were confirmed positive.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.